Ambys Medicines Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 61

Employees

  • Latest Deal Type
  • M&A

Ambys Medicines General Information

Description

Developer of regenerative medical therapies intended to cure serious liver diseases. The company's medical therapies help in restoring liver function, prevent the progression of liver disease, and treat the devastating complications of liver failure, enabling patients suffering from chronic liver diseases to get relief through cell therapy and regenerative therapeutics.

Contact Information

Website
www.ambys.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 131 Oyster Point Boulevard
  • Suite 200
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 131 Oyster Point Boulevard
  • Suite 200
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ambys Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 23-Feb-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 21-Dec-2021 Completed Pre-Clinical Trials
2. Early Stage VC 08-Aug-2018 $80M $140M Completed Product Development
1. Early Stage VC (Series A) 08-Aug-2018 $60M $60M Completed Product Development
To view Ambys Medicines’s complete valuation and funding history, request access »

Ambys Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Ambys Medicines’s complete cap table history, request access »

Ambys Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of regenerative medical therapies intended to cure serious liver diseases. The company's medical therapies hel
Drug Discovery
South San Francisco, CA
61 As of 2023

Nantes, France
 

Hangzhou, China
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ambys Medicines Competitors (29)

One of Ambys Medicines’s 29 competitors is GoLiver Therapeutics, a Venture Capital-Backed company based in Nantes, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GoLiver Therapeutics Venture Capital-Backed Nantes, France
Qihan Biotech Venture Capital-Backed Hangzhou, China
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
HepaTx Venture Capital-Backed Palo Alto, CA
Tioga Pharmaceuticals Formerly VC-backed San Diego, CA
You’re viewing 5 of 29 competitors. Get the full list »

Ambys Medicines Patents

Ambys Medicines Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023086958-A1 Methods of producing and using human hepatocytes and related compositions Inactive 12-Nov-2021
WO-2022164807-A2 Genetically modified hepatocyte populations Inactive 26-Jan-2021
WO-2022164807-A3 Genetically modified hepatocyte populations Inactive 26-Jan-2021
WO-2022140261-A1 Biliary delivery methods, compositions and kits for use therein Inactive 22-Dec-2020
CA-3158153-A1 Tropolone derivatives and tautomers thereof for iron regulation in animals Pending 16-Oct-2019 C07D307/12
To view Ambys Medicines’s complete patent history, request access »

Ambys Medicines Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ambys Medicines Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Laurion Capital Management Hedge Fund Minority
Schroders Capital Asset Manager Minority
Smilegate Investment Venture Capital Minority
Takeda Ventures Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ambys Medicines FAQs

  • When was Ambys Medicines founded?

    Ambys Medicines was founded in 2018.

  • Where is Ambys Medicines headquartered?

    Ambys Medicines is headquartered in South San Francisco, CA.

  • What is the size of Ambys Medicines?

    Ambys Medicines has 61 total employees.

  • What industry is Ambys Medicines in?

    Ambys Medicines’s primary industry is Drug Discovery.

  • Is Ambys Medicines a private or public company?

    Ambys Medicines is a Private company.

  • What is Ambys Medicines’s current revenue?

    The current revenue for Ambys Medicines is .

  • How much funding has Ambys Medicines raised over time?

    Ambys Medicines has raised $187M.

  • Who are Ambys Medicines’s investors?

    Alexandria Venture Investments, Laurion Capital Management, Schroders Capital, Smilegate Investment, and Takeda Ventures are 5 of 6 investors who have invested in Ambys Medicines.

  • Who are Ambys Medicines’s competitors?

    GoLiver Therapeutics, Qihan Biotech, Inovio Pharmaceuticals, HepaTx, and Tioga Pharmaceuticals are some of the 29 competitors of Ambys Medicines.

  • When was Ambys Medicines acquired?

    Ambys Medicines was acquired on 23-Feb-2023.

  • Who acquired Ambys Medicines?

    Ambys Medicines was acquired by Cytotheryx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process